According To Gina Guidelines What Is The Preferred Controller And
The GINA (Global Initiative for Asthma) treatment strategy recommends that all adults and adolescents with asthma should receive ICS-containing controller treatment. This can be either as a symptom-reliever or as maintenance-and-reliever therapy (MART). For children 6-11 years old, the preferred Step 3 treatment is low dose ICS-LABA or medium dose ICS. The 2019 guidelines also recommend low-dose ICS-LABA as the preferred controller for children 6-11 years old in Step 2, with less effective options available. For patients with moderate-severe asthma, the preferred regimen is MART with ICS-formoterol, which is approved in many countries. The preferred reliever medication in Steps 3-5 is sometimes being misinterpreted and should be low-dose ICS-LABA or medium dose ICS.
According to the GINA guidelines, for Step 3 in adolescents and adults, the preferred controller and reliever are as follows:
Preferred Controller: For Step 3, the preferred controller in adolescents and adults is an inhaled corticosteroid (ICS) combined with a long-acting beta2-agonist (LABA).
Alternative Reliever: In addition, for patients with moderate-severe asthma, the preferred regimen is maintenance-and-reliever therapy (MART) with ICS-formoterol, which is approved in many countries. The preferred reliever medication in Steps 3-5 is sometimes being misinterpreted and should be low-dose ICS-LABA or medium dose ICS.
It's crucial to consult a healthcare professional for personalized medical advice and proper asthma management based on individual needs and conditions.
Sources
Related Questions
Work fast from anywhere
Stay up to date and move work forward with BrutusAI on macOS/iOS/web & android. Download the app today.